What is confounding by indication best described as?

What is confounding by indication best described as?

• A. When treatment choice is related to the underlying condition, confounding the treatment effect.
• B. When patient age influences medication dose.
• C. When geographic location influences outcomes.
• D. When randomization is improperly performed.

Answer: (A)

Confounding by indication happens when the reason a patient receives a particular treatment is tied to how severe their disease or prognosis is. Because the treatment choice is made based on the underlying condition, the observed effect of the treatment on outcomes becomes mixed with the effect of the condition itself. For example, sicker patients often get a more aggressive therapy, so if their outcomes are worse, it can look like the therapy is harmful even if the treatment isn’t the cause. Conversely, healthier patients might be selected for a treatment and appear to benefit more, not because the treatment is superior, but because their baseline prognosis was better. This is exactly described by treatment choice being related to the underlying condition, confounding the treatment effect. Other scenarios—like age influencing dose, geographic differences in outcomes, or randomization problems—reflect different sources of bias or confounding, not this specific situation. To address confounding by indication in nonrandomized studies, researchers use methods like randomization, propensity scores, stratification, or instrumental variables to balance the differences related to the indication.

Confounding by indication happens when the reason a patient receives a particular treatment is tied to how severe their disease or prognosis is. Because the treatment choice is made based on the underlying condition, the observed effect of the treatment on outcomes becomes mixed with the effect of the condition itself. For example, sicker patients often get a more aggressive therapy, so if their outcomes are worse, it can look like the therapy is harmful even if the treatment isn’t the cause. Conversely, healthier patients might be selected for a treatment and appear to benefit more, not because the treatment is superior, but because their baseline prognosis was better. This is exactly described by treatment choice being related to the underlying condition, confounding the treatment effect. Other scenarios—like age influencing dose, geographic differences in outcomes, or randomization problems—reflect different sources of bias or confounding, not this specific situation. To address confounding by indication in nonrandomized studies, researchers use methods like randomization, propensity scores, stratification, or instrumental variables to balance the differences related to the indication.